NASDAQ · Analyst Forecast

Tandem Diabetes Care, Inc. (TNDM) Stock Forecast & Price Target

$17.06 NASDAQ: TNDM Market Cap $1.19B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Tandem Diabetes Care, Inc. (TNDM), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Tandem Diabetes Care, Inc., analysts forecast revenue rising from $1.00B in 2025 to $1.64B in 2030; the average estimate for 2030 earnings per share is $1.87; with published estimates ranging from $1.82 to $1.95; 18 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$17.06
Consensus targetThe average of the price targets analysts have published.$23.19
Median targetThe middle target, less affected by a single outlier.$20.50
Highest targetThe most optimistic published target.$40.00
Lowest targetThe most pessimistic published target.$15.50
Difference from priceHow far the consensus target sits from today’s price.+35.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$997.76M$1.00B$1.01B15
2026$1.07B$1.08B$1.11B18
2027$1.13B$1.15B$1.19B18
2028$1.27B$1.32B$1.43B18
2029$1.44B$1.47B$1.51B13
2030$1.60B$1.64B$1.69B13

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.11−$2.09−$2.0615
2026−$0.70−$0.60−$0.5018
2027−$0.39$0.04$0.5218
2028$0.29$0.72$1.6218
2029$1.34$1.38$1.4413
2030$1.82$1.87$1.9513

Tandem Diabetes Care, Inc. (TNDM) forecast — frequently asked questions

What is the analyst price target for Tandem Diabetes Care, Inc.?

Analysts covering Tandem Diabetes Care, Inc. (TNDM) have a consensus price target of $23.19, 35.9% above the current price of $17.06. Published targets range from $15.50 to $40.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Tandem Diabetes Care, Inc.'s earnings?

The average analyst estimate for Tandem Diabetes Care, Inc. (TNDM) earnings per share in 2030 is 1.87, with individual estimates between 1.82 and 1.95.

How much revenue is Tandem Diabetes Care, Inc. expected to make?

Analysts forecast Tandem Diabetes Care, Inc. (TNDM) revenue of $1.64B in 2030, based on 13 published estimates.

How many analysts cover TNDM?

18 analysts contribute estimates for Tandem Diabetes Care, Inc. (TNDM). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.